Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
暂无分享,去创建一个
Y. Sugiyama | Y Sugiyama | S. Terashita | Y Naritomi | S Terashita | S Kimura | A Suzuki | A Kagayama | Y. Naritomi | A. Suzuki | A. Kagayama | Yuichi Sugiyama | S. Kimura | A. Suzuki | Sumihisa Kimura | Yoichi Naritomi
[1] S. Higuchi,et al. Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.
[2] M. Rowland,et al. Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model , 1986, The Journal of pharmacy and pharmacology.
[3] Pravin Chaturvedi,et al. Design principles for orally bioavailable drugs , 1996 .
[4] P. Neuvonen,et al. Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam. , 1996, Pharmacology & toxicology.
[5] B. Levet-Trafit,et al. Estimation of oral drug absorption in man based on intestine permeability in rats. , 1996, Life sciences.
[6] D. Bloedow,et al. Pharmacokinetics of diltiazem in selected animal species and human beings. , 1982, The American journal of cardiology.
[7] M. Sari,et al. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. , 1991, Journal of medicinal chemistry.
[8] R. Obach,et al. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[9] R. Oishi,et al. First-pass metabolism of omeprazole in rats. , 1994, Journal of pharmaceutical sciences.
[10] M. Katashima,et al. Metabolic Fate of Zolpidem (IV) : Serum and Plasma Protein Binding of zolpidem and Its Transfer into the Blood Cells in Rats, Monkeys and Humans , 1993 .
[11] G R Wilkinson,et al. Clearance approaches in pharmacology. , 1987, Pharmacological reviews.
[12] J B Houston,et al. Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. , 1997, Drug metabolism reviews.
[13] H. Ochs,et al. Pharmacokinetic model of diltiazem. , 1983, Arzneimittel-Forschung.
[14] J. M. Díaz-García,et al. Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury. , 1992, Journal of pharmaceutical sciences.
[15] M. Murray,et al. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.
[16] J B Houston,et al. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. , 1994, Biochemical pharmacology.
[17] T. Hashimoto,et al. Metabolic Fate of Zolpidem (I) : Pharmacokinetics of Zolpidem in Rats after Single Dosing , 1993 .
[18] Kölle Eu,et al. Pharmacokinetic model of diltiazem. , 1983 .
[19] Y. Tokuma,et al. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.
[20] Y. Tokuma,et al. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[21] C. Bonfils,et al. Oxidative metabolism of zolpidem by human liver cytochrome P450S. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[22] C. Regårdh,et al. Pharmacokinetics and metabolism of omeprazole in animals and man--an overview. , 1985, Scandinavian journal of gastroenterology. Supplement.
[23] E. Leboeuf,et al. Deacetylation of diltiazem by rat liver. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[24] T Ishizaki,et al. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. , 1997, Pharmacology & therapeutics.
[25] K H Antonin,et al. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. , 1976, The Journal of pharmacology and experimental therapeutics.
[26] Leslie Z. Benet,et al. Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .
[27] Y. Sugiyama,et al. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes. , 1997, The Journal of pharmacology and experimental therapeutics.
[28] B. Hoener,et al. Predicting the hepatic clearance of xenobiotics in humans from in vitro data , 1994, Biopharmaceutics & drug disposition.
[29] S. Higuchi,et al. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.
[30] G R Wilkinson,et al. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. , 1977, The Journal of pharmacology and experimental therapeutics.
[31] G. Siest,et al. Induction of plasma and tissue enzymes by drugs: significance in toxicological studies. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[32] R C Chou,et al. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.